Catalyzing a Global Ecosystem for Scale-up of Wolbachia-based Interventions to Prevent Dengue and Aedes-Borne Diseases
In plain English
AI plain-English summaryDengue-carrying mosquitoes are becoming resistant to insecticides, and climate change is expanding their habitat. This project aims to build the global infrastructure needed to deploy a biological alternative: infecting mosquitoes with *Wolbachia* bacteria, which block the insects from transmitting dengue and other viruses. The problem is that while *Wolbachia*-based interventions have shown impressive results in field trials, no system exists to scale them up to the hundreds of millions of people at risk. The researchers—the Clinton Health Access Initiative and the Innovative Vector Control Consortium—plan to create that system. They will work with governments in at least four countries across Central America, Southeast Asia, and sub-Saharan Africa to incorporate *Wolbachia* into national dengue strategies. They will also map out the supply chain for producing and distributing the bacteria-treated mosquitoes, and develop financing mechanisms to pay for it all. If successful, this work could transform dengue control from a patchwork of pilot projects into a coordinated, government-led global programme. The impact would be felt in the everyday lives of people in tropical and subtropical cities, where dengue outbreaks currently overwhelm hospitals and disrupt communities.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Discretionary AwardPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know